Openfund

CORDIS · POTENTIAL

Platform Optimisation To Enable NanomaTerIAL safety assessment for rapid commercialisation

Code
POTENTIAL
Programme
HORIZON
Call
HORIZON-CL4-2022-DIGITAL-EMERGING-01-35
Status
SIGNED
Period
2023-01-01 – 2026-12-31
Total cost (whole consortium)2 999 788 €
EU contribution (whole consortium)2 999 788 €
EU contribution to Bulgarian participants193 538 €

Official data · CORDIS · synced 2026-10-18 03:29 · official record

Participants

OrganisationsRoleCountryGrant
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRIcoordinatorIT677 375 €
ROYAL COLLEGE OF SURGEONS IN IRELANDparticipantIE338 712 €
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNEparticipantES338 688 €
LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGYparticipantLU338 638 €
UNIVERSITAET LEIPZIGparticipantDE241 900 €
MYBIOTECH GMBHparticipantDE193 550 €
EAST EUROPEAN RESEARCH AND INNOVATION ENTERPRISE LTDparticipantBG193 538 €
GREENDECISION SRLparticipantIT193 538 €
INNOVA SRLparticipantIT193 538 €
GRAPHENEA SAparticipantES145 162 €
UNIVERSITE PARIS 13participantFR145 150 €
Zhejiang Universityassociated partnerCN

Description

Advanced Nanomaterials (Ad-NMs) will lead a new industrial revolution and accelerate the transition to greener technologies and better health care. However, lack of practical and reliable protocols to evaluate Ad-NMs' potential hazards and risks has hindered innovation so far. POTENTIAL will generate a methodological framework comprising a set of harmonised protocols for characterisation, testing, grouping and read-across of Ad-NMs, that meet regulatory requirements for risk assessment, by improving:a) Advanced imaging protocols to quantify and characterize the intrinsic and extrinsic properties of Ad-NMs in complex matrices, using conventional analytical methods. b) Protocols to trace the evolution of Ad-NMs properties throughout their lifecycle, and methodologies for accelerated testing. c) in vitro multi-cellular models, in vivo (invertebrate) models, and ecotoxicological models for assessing the environmental and health hazard of Ad-NMs.Grouping and read-across approaches will build up on results from existing Horizon initiatives (GRACIOUS, SUNSHINE and HARMLESS), and will generate novel algorithms for similarity assessment, grouping hypotheses and Integrated Approaches to Testing and Assessments (IATAs).The protocols generated in the project will be validated through peer-reviewed publications and disseminated in Open Access. Furthermore, we will engage with the relevant standardisation bodies and organisations (OECD, ISO, CEN) to ensure that our approach can be translated into industry standards.The consortium comprises 11 European partners and 1 international partner (China), among which 4 high-tech SMEs specialised in Ad-NMs, and a high-tech incubator / accelerator. POTENTIAL contributes to the Horizon Europe workprogram by helping establish appropriate methods for cost-efficient assessment and prediction of the health and environmental effects of Ad-NMs, as well as supporting the inclusion of new methods to support safe-and-sustainable-by-design.

Official data · CORDIS · synced 2026-10-18 03:29 · official record · Licence: © European Union, CC BY 4.0 (Commission reuse policy).